Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 1
Submit an article Journal homepage
460
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin

Carrie McAdam-Marx University of Utah Department of Pharmacotherapy, Salt Lake City, Utah, USACorrespondence[email protected]
,
Junhua Yu University of Utah Department of Pharmacotherapy, Salt Lake City, Utah, USA
,
Jonathan Bouchard Novo Nordisk, Princeton, NJ, USA
,
Mark Aagren Novo Nordisk, Princeton, NJ, USA
&
Diana I. Brixner University of Utah Department of Pharmacotherapy, Salt Lake City, Utah, USA
Pages 191-201 | Accepted 22 Oct 2009, Published online: 18 Nov 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Eric L. Johnson, Juan P. Frias & Jennifer M. Trujillo. (2018) Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgraduate Medicine 130:4, pages 365-374.
Read now
Michael Grabner, James Chu, Swetha Raparla, Ralph Quimbo, Steve Zhou & Joseph Conoshenti. (2013) Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial. Postgraduate Medicine 125:3, pages 204-213.
Read now
Dong-Churl Suh & Mark Aagren. (2011) Cost–effectiveness of insulin detemir: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 641-655.
Read now

Articles from other publishers (7)

Thomas G Wadsworth, Glenda G Carr, Karl Madaras-Kelly, Richard Remington & Justin Bell. (2021) Weight gain associated with insulin detemir vs insulin glargine in clinical practice: A retrospective longitudinal cohort study. American Journal of Health-System Pharmacy 78:5, pages 401-407.
Crossref
Lawrence Blonde, Timothy S. Bailey, Jason Chao, Terry A. Dex, Juan Pablo Frias, Luigi F. Meneghini, Michelle Roberts & Vanita R. Aroda. (2019) Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. Advances in Therapy 36:9, pages 2310-2326.
Crossref
Mhd Wasem Alsabbagh, Kerry Mansell, Lisa M. Lix, Gary Teare, Yvonne Shevchuk, Xinya Lu, Anne Champagne & David F. Blackburn. (2015) Trends in Prevalence, Incidence and Pharmacologic Management of Diabetes Mellitus Among Seniors Newly Admitted to Long-Term Care Facilities in Saskatchewan between 2003 and 2011. Canadian Journal of Diabetes 39:2, pages 138-145.
Crossref
Juliet P. Wallace, Jessica L. Wallace & M. Shawn McFarland. (2014) Comparing Dosing of Basal Insulin Analogues Detemir and Glargine. Annals of Pharmacotherapy 48:3, pages 361-368.
Crossref
Marie Jakobsen, Mette Dalsgaard, Morten Hørmann & Daniél Vega Møller. (2012) Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients. BMC Endocrine Disorders 12:1.
Crossref
Chrysoula Pipili, Chrysostomos Dimitriadis, Nigar Sekercioglu, Joanne M. Bargman & Dimitrios D. Oreopoulos. (2011) Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease. International Urology and Nephrology 44:1, pages 167-171.
Crossref
Lauren J. Lee, Julie Anderson, Shonda A. Foster, Sheila M. Corrigan, David M. Smith & Suellen Curkendall. (2010) Predictors of Initiating Rapid-Acting Insulin Analog Using Vial/Syringe, Prefilled Pen, and Reusable Pen Devices in Patients with Type 2 Diabetes. Journal of Diabetes Science and Technology 4:3, pages 547-557.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.